Correlation among macrophage inflammatory protein 1 α levels, matrix metalloproteinase 8 levels, and systemic inflammation in rheumatoid arthritis: Comment on the articles by Yamanaka et al and Mattey et al [4]

Arthritis and Rheumatism

Volumn 44, Issue 12, 2001, Pages 2940-2941

  Kullich, Werner C ^a   Klein, Gert ^b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b Rehabilitation Centre for Rheumatic Diseases   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; CHEMOKINE; COLLAGEN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MATRIX METALLOPROTEINASE; NEOPTERIN; NEUTROPHIL COLLAGENASE; STROMELYSIN;

CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MATRIX METALLOPROTEINASE 8;

EID: 0035670580     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200112)44:12<2940::AID-ART487>3.0.CO;2-R     Document Type: Letter

References (6)

1. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis
2. Cheung NT Serum matrix metalloproteinase 3 as a predictor of joint destruction in rheumatoid arthritis: Comment on the article by Yamanaka et al
3. Prevention of cartilage breakdown by matrix metalloproteinase inhibition: A realistic therapeutic target?
4. Chemokines: Leucocyte recruitment and activation cytokines
5. Macrophage inflammatory protein-1α: A novel chemotactic cytokine for macrophages in rheumatoid arthritis
6. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis